Work

Abstract 2774: Complete results from a phase Ia dose-escalation and dose-expansion study of single-agent MetMAb, a monovalent antagonist antibody to the receptor MET, administered intravenously in patients with locally advanced or metastatic solid tumors

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-2774

Authors: Ravi Salgia, Amy C. Peterson, John Bothos, Steve Eppler, Wei Yu, Priti Hegde, Bob Yauch, Jiping Zha, Mark J. Ratain, David Geary, Elayne Wesolowsky, Marjorie LaRosiliere, Premal Patel, Rebecca Moss

Institutions: University of Chicago, Genentech, Rutgers Cancer Institute

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1971493016

Cites:

Cited by: 2

Related to: 10